Atul Butte’s Keynote Presentation at Exponential Medicine, Coronado, California, November, 2015...
Classics place an emphasis on sales but glue themselves to the middle of the road when it comes to most management practices...
Dr. Atul Butte of UCSF gave a keynote address at Dreamforce today on the value we can gain from big data...
Petersen is a software developer who has worked extensively with drug discovery researchers to develop online solutions to complex scientific...
The annual trip to BIO provides One Nucleus with an excellent opportunity to build on our international collaborations to consolidate the global...
A new research marketplace for biotech startups has been launched by One Nucleus, the life science membership guardian of the Cambridge life...
The list of IT vendors and service providers that have yet to strike a deal with AstraZeneca ($AZN) in 2015 keeps getting shorter...
This story appeared in the San Diego Business Journal. Making a drug used to fall to Big Pharma, costing a billion dollars and requiring resources...
In the world of drug discovery, pharmaceutical companies face a very sobering statistic – more than 90% of the drugs that reach clinical testing...
I’ve been thinking a lot lately about how to optimize for ligand affinity. Of course, this is a central theme of all drug discovery projects. At...
Search
Categories
- Artificial Intelligence (7)
- Challenges (63)
- Discovery & Innovation (196)
- Industry Trends (211)
- Infographics (17)
- News & Events (88)
- Open Science (39)
- Outsourcing (73)
- Press Releases (145)
- Research Exchanges (58)
- Research Services (96)
- Scientist In The News (152)
- Supplier Spotlight (50)
- Tech Snapshot (37)
- Webinars (34)